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Abstract
Background: To investigate factors associated with involuntary admissions to hospital pursuant to a social services
act of patients with substance use disorder by comparing the socio-demographic characteristics, substance use, and
psychiatric comorbidities with voluntarily admitted patients.
Methods: This cross-sectional study compared two groups admitted to combined substance use disorder and
psychiatry wards. Sixty-five patients were involuntarily admitted pursuant to the Social Services Act and 137 were
voluntarily admitted. The International Classification of Diseases and Related Health Problems was used for
diagnostic purposes regarding substance use disorders, type and severity of psychiatric problems, and level of
functioning. Socio-demographic variables were measured using the European Addiction Severity Index, and the
Symptom Checklist-90-R instruments were used to evaluate the range of psychological problems and
psychopathological symptoms. Logistic regression was performed to investigate the relationship between
involuntary admissions and patients characteristics.
Results: Patients who had been involuntarily admitted were more likely to be females, had utilized public welfare
services more often, presented more severe substance use patterns, and had a history of more frequent visits to
physicians for somatic complaints in the last 6 months, they also had fewer comorbid mental disorders. Still,
considerable burdens of comorbid substance use disorders and mental disorders were observed both among
involuntary and voluntary admitted patients.
Conclusions: More attention is required for involuntarily admitted patients in order to meet the needs associated
with complex and mixed disorders. In addition, treatment centers should offer diagnostic options and therapy
regarding substance use, psychiatric and somatic disorders.
Keywords: Substance use disorder, Comorbidity, Involuntary admission, Mental disorders
Background
Substance dependence is a chronic relapsing disease that
typically leads to psychiatric, somatic, and social comor-
bidities, often with shortened life expectancy [1]. In con-
trast to other patients with chronic diseases, patients
with substance use disorders (SUDs) sometimes refuse
treatment owing to denial of their own disorder, feelings
of hopelessness, or a negative attitude toward treatment
[2,3]. In many countries, the involuntary admission of
SUD patients to institutions has been a controversial op-
tion when voluntary care has proven unsuccessful [4].
As of 2001, 73 of 90 countries worldwide provided some
form of compulsory commitment (acute or rehabilita-
tive) motivated by the intent to protect an otherwise le-
gally capable individual who is in a self-destructive and
vulnerable situation because of substance use [5]. In the
literature, three main legislative domains have been
described as foundations for the mandated treatment of
SUD patients: mental health care acts or social services
acts (in combination called civil commitment), and
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criminal justice acts. Although most countries may apply
one or more of these acts to SUD patients, not all coun-
tries provide all three alternatives [4]. Literature from
the United States has been dominated by drug courts’
studies of treatment as an alternative to prison [6]. Psy-
chiatric research often reports on involuntary versus vol-
untary treatment. Less focus has been paid to SUD
patients in treatment pursuant to the mental health care
acts, although a considerable proportion of these
patients are SUD patients [7,8]. Comorbid disorders are
pervasive in mental health and SUD treatment settings,
and there is a need for health service providers both in
Norway and in other countries to develop better inte-
grated services that addresses both problem areas [9].
The Norwegian Mental Health Care Act (§§ 3.2 and
3.3) is designed for patients based on their need for psy-
chiatric care. Involuntary admission is an option only for
persons who are found by a medical professional or
psychologist to be incapable of assessing their own need
for care. Such incapacity is only stated when patients are
severely mentally ill (psychotic) and may be a danger to
themselves or others [10]. In 2010, there were approxi-
mately 8300 involuntary admissions to mental health
care units in Norwegian hospitals pursuant to this law
[11]. Approximately one-third of patients involuntarily
admitted to mental health care hospitals had a substance
use disorder [12].
The Norwegian Social Services Act (§ 6.2) warrants in-
voluntary interventions for non-psychotic adult patients
with SUDs. The act covers an option for retention (up
to three months) when the health of the patient is ser-
iously at risk because of extensive and prolonged sub-
stance use, and voluntary efforts have shown to be
insufficient. In Norway, voluntarily and involuntarily ad-
mitted SUD patients are often treated within the same
wards, and using the same kind of therapy. In the acute
phase, the main target of retention is to provide life-
saving treatment; in the longer term, the aim is to mo-
tivate patients to enter voluntary treatment [13]. During
2010, only 106 decisions were made for the involuntary
admission of SUD patients to institutions pursuant to
the Social Services Act [14].
Involuntary commitment of non-psychotic SUD
patients, although a relatively marginal phenomenon, is
controversial. To force someone to treatment has many
ethical considerations and can also be a traumatic ex-
perience that may result in a crisis. Worldwide, there is
growing concern regarding ethical issues related to the
use of involuntary treatment. Such interference with per-
sonal autonomy should not be applied without an
evidence-based foundation [15]. In Sweden, the
phenomenon of SUD patients in compulsory care pursu-
ant to social services acts has to some extend been
explored [16]. However, the acts in these two countries
differ considerably and Swedish results may not be dir-
ectly applicable to Norwegian settings. Thus far, little is
known about the characteristics of involuntarily admit-
ted patients in Norway and the factors associated with
these admissions. This study addresses this knowledge
gap and focuses on SUD patients who have been invol-
untarily admitted to institutions.
Aims of the study
The aims of the study were to investigate factors asso-
ciated with involuntary admission to treatment institu-
tions by describing the socio-demographic characteristics,
substance use patterns, and psychiatric comorbidities
among SUD-patients involuntarily admitted to hospital
pursuant to the Social Services Act by comparing them
with voluntarily admitted patients.
Methods
Study subjects
This cross-sectional study compared two groups: invol-
untarily and voluntarily admitted patients to substance
use disorder and psychiatry wards. Involuntarily admit-
ted (IA) patients were included from three different pub-
licly funded treatment centers in the southeastern part
of Norway. The centers were located in Kristiansand,
Tønsberg, and Oslo, and had 4, 4, and 3 beds for IA
patients, respectively. All of the voluntarily admitted
(VA) patients were from the same ward of the Kristian-
sand center as the IA patients. All wards were multidis-
ciplinary (psychiatrists, psychologists, social workers,
occupational therapists, specialized nurses, and other
trained staff ) and had specialized units that offered treat-
ment for patients with primary SUD often combined
with mental disorders (except psychosis). Treatment
included assessments of somatic and mental health, with
diagnoses based on a structured interview and examin-
ation in accordance with the International Classification
of Diseases and Related Health Problems, 10th Revision
(ICD-10); pharmacotherapy; cognitive milieu therapy;
and individual motivation enhancement. The patient
population was recruited mainly from urban and subur-
ban areas.
Recruitment for the study continued consecutively
from January 1, 2009 to May 31, 2011. The criteria for
inclusion were as follows: substance abuse or depend-
ence, age ≥ 18 years, understanding/speaking the Norwe-
gian language and at least 3 weeks admission.
Before inclusion, both the IA group and the VA group
of patients were detoxified, verified by either negative
urine tests of alcohol, opioids, central stimulants
(amphetamines, methamphetamines, and cocaine), ben-
zodiazepines, and cannabis, or a minimum of 14 days
spent in detoxification to establish baseline values not
influenced by withdrawal symptoms. Patients with
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mental retardation (IQ < 70) who were not able to
understand the questionnaires were excluded. Because
pregnant SUD patients are treated in special wards, they
were not included in this study.
Altogether, 103 consecutive IA patients were identi-
fied. Fifteen did not meet the inclusion criteria (12 be-
cause their stay was too short, and 3 because of
insufficient mental capacity), 11 were not asked to par-
ticipate owing to logistical issues. Of the 77 patients eli-
gible for inclusion 12 refused to participate. Therefore,
the rate of consent to participate was 84% (65 patients).
There were 223 VA patients identified; 72 patients were
excluded (69 because their stay was too short, 3 because
of insufficient mental capacity). Of the remaining 151
VA patients, 14 refused to participate. Therefore, rate of
consent in the VA group was 91% (137 patients).
The study was approved by The Regional Committee
for Research Ethics in Norway (REK 08/206d, 2008/
2900, 09/2413) and by the Privacy Issues Unit, Norwe-
gian Social Science Data Services (NSD no. 18782).
Written informed consent was obtained from all study
participants.
Instruments and measures
The ICD-10 was used for diagnostic purposes regarding
current substance use disorders, current type and sever-
ity of psychiatric problems, and level of functioning [17].
All patients were interviewed according to a clinical psy-
chiatric examination supported by the Mini-International
Neuropsychiatric Interview (MINI) version 2005. The
MINI is a short psychiatric interview for the assessment
of psychiatric disorders in accordance with the Diagnos-
tic and Statistical Manual of Mental Disorders, Fourth
Edition (DSM-IV) and ICD-10 classification systems
[18], and has high acceptance and validity [19,20]. The
interviews were conducted by senior psychiatrists and
psychologists who had many years of clinical and re-
search experience with the psychiatric assessment of
patients with physical disorders. In the statistical analysis,
psychiatric diagnoses were categorized as serious mental
illness (F 20–39, which includes schizophrenia and mood
disorders) or other mental illnesses (F 40–99) [21].
Injecting illicit drugs during the past 6 months before ad-
mission and lifetime prevalence of overdoses were used
as indicators for severe substance use disorder.
Socio-demographic variables were measured using the
European Addiction Severity Index (EuropASI); a per-
sonal, structured interview designed for both clinical and
research purposes. It includes 7 areas: medical status, em-
ployment and support status, drug and alcohol use, legal
status, family history, family and social relationships, and
psychiatric status [22]. The EuropASI interviews were per-
formed by trained and certified staff. Specific substance
use patterns based on the EuropASI were dichotomized
into drug consumption at least once weekly versus less
than weekly. The Symptom Checklist-90-R (SCL-90-R) in-
strument was used to evaluate the range of psychological
problems and symptoms of psychopathology. The SCL-90
-R test contains 90 items, measures 9 primary symptom
dimensions, and provides an overview of a patient’s symp-
toms and their intensity. Each of the 90 items is rated on a
five-point Likert-type scale, ranging from “not at all” (0) to
“extremely” (4): higher values indicate greater symptom
severity during the past week. The Global Symptom Index
(GSI) score was used to assess the level of general psycho-
logical distress [23].
Analysis and statistical methods
Continuous variables are reported with means and
standard deviations. Categorical variables are reported as
frequencies. The independent sample t-test, Chi-squared
test, and Fisher’s exact test were used to test for statisti-
cally significant differences between groups. Logistic re-
gression was performed to investigate the relationship
between involuntary admissions and patient characteris-
tics. Results are presented with 95% confidence intervals.
Continuous variables were checked for correlation with
Spearman’s rho. None of the included continuous vari-
ables had a correlation exceeding 0.7. The number of
cases in the sample restricted the predictors included in
the model. From univariate analysis, variables with a P-
value < 0.10 were included in the multivariate analyses
except “overdoses on drugs” because of multicollinearity
with the variable “injecting illicit drugs”. The threshold
for statistical significance was P < 0.05. Analyses were
performed using SPSS 18.0 Software (SPSS Inc., Chicago,
IL, USA).
Results
Patient characteristics
We found several differences between the IA and the VA
groups (Table 1). There were significantly more female
patients among the IA patients compared with the VA
patients (48% vs. 27%; P = 0.004). During the 6 months
prior to admission, significantly more IA patients
received financial support from public welfare benefits,
and were more often injecting illicit drugs. In addition,
IA patients had experienced more overdoses during their
lifetime compare with VA patients. IA patients had also
significantly more frequent visits to physicians for som-
atic complaints during the 6 months prior to admission.
However, the burden of psychological symptoms (SCL-
90-R and suicide attempts) was higher in the VA group.
Mental health diagnoses and substance use disorders
All patients met the ICD-10 criteria for current sub-
stance dependence or abuse. IA patients were using al-
cohol, benzodiazepines and other sedatives, and heroin
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Table 1 Baseline socio-demographic variables and mental stress scores for substance abuse patients voluntarily or
involuntarily admitted to addiction treatment centers
Involuntary n/ Voluntary n Involuntary Voluntary P-value
Age, mean (SD) 65/137 29 (10.6) 31 (8.9) 0.229
Females (%) 65/137 31 (47.7) 37 (27) 0.004
Education
Mean years in primary and high school (SD) 59/130 10.53 (1.4) 10.59 (1.6) 0.783
Mean years in college/university (SD) 59/130 0.17 (0.8) 0.31 (1.0) 0.352
Sources of financial supporta, c
Employment (%) 60/130 6 (10.0) 24 (18.5) 0.137
Unemployment compensation (%) 60/130 2 (3.3) 4 (3.1)
Public welfare benefits (%) 62/135 59 (95.2) 115 (85.2) 0.043
Partner, family, or friends (%) 60/130 17 (28.3) 37 (28.5) 0.985
Illegal activity (%) 60/130 24 (40.0) 47 (36.2) 0.610
Prostitution (%) 60/130 3 (5.0) 1 (0.8)
Living arrangementc
With partner (%) 60/130 8 (13.3) 11 (8.5) 0.298
Alone (%) 60/130 31 (51.7) 62 (47.7) 0.610
With family (%) 60/130 9 (15.0) 26 (20.0) 0.409
Homeless (%) 60/130 9 (15.0) 16 (12.3) 0.610
Institution (%) 60/130 2 (3.3) 15 (11.5)
Visits to physician for somatic complaintsc (%) 60/130 24 (40.0) 32 (24.6) 0.031
Injecting illicit drugc (%) 61/134 43 (70.5) 62 (46.3) 0.002
Drug overdosesd (%) 59/130 41 (69.5) 63 (48.5) 0.007
Suicide attemptsd (%) 60/131 23 (38.3) 71 (54.2) 0.042
Mental stress score
SCL-90-R GSIb, mean (SD) 62/135 1.04 (0.7) 1.28 (0.7) 0.023
aSome have more than one source of financial support.
bSCL-90-R GSI, Symptom Check List-90-revised, Global Symptom Index.
cLast 6 months before admission, dLifetime prevalence.
Table 2 Substance use disorders with respect to ICD-10 diagnosis and Addiction Severity Index (ASI) of patients
voluntarily and involuntarily admitted to addiction treatment centers
Involuntary n/ Voluntary n Involuntary (%) Voluntary (%) P-value
F10-19 Substance use disorders
Single substance 65/137 9 (13.8) 32 (23.4) 0.116
Two substances 65/137 11 (16.9) 30 (21.9) 0.412
Three or more substances 65/137 45 (69.2) 75 (54.7) 0.050
ASI, Substance Abuseab
Alcohol 60/132 29 (48.3) 41 (31.1) 0.021
Heroin 61/134 21 (34.4) 18 (13.4) 0.001
Other opiates 60/130 11 (18.3) 25 (19.2) 0.883
Benzodiazepines, other sedatives 60/134 39 (65.0) 63 (47.0) 0.020
Amphetamines 62/135 35 (56.5) 67 (49.6) 0.374
Cannabis 61/133 32 (52.5) 71 (53.4) 0.905
Cocaine, inhalants, hallucinogens 60/132 12 (20.0) 18 (13.6) 0.260
aSome patients abuse more than one substance, bLast 6 months before admission.
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significantly more often than VA patients (Table 2). Sig-
nificantly more IA patients received “no mental diagno-
ses”, but among those with comorbid mental disorders,
no significant differences were observed between the
two groups regarding mental health diagnosis. The most
common mental diagnoses among both IA and VA
patients were F40-49 neurotic disorders, F 90 attention-
deficit hyperactivity disorder (AD/HD), and F30-39
mood disorders. Among the personality disorders (F 60),
emotionally unstable personality disorder (F 60.3) was
the most common in both groups (8% of IA patients and
7% of VA patients) (Table 3).
Multiple logistic regression analysis was used to inves-
tigate whether being involuntarily admitted to an institu-
tion was associated with any specific patterns. Women,
receiving public welfare benefits, and more frequent vis-
its to physicians for somatic complains, or injection of
drugs during 6 months prior to treatment were asso-
ciated with involuntarily admission pursuant to the So-
cial Services Act (Table 4). Neither the severity of the
mental illness nor the number of substance use diagno-
ses were associated with being involuntarily admitted.
Discussion
Overall, SUD patients in the IA group were character-
ized by severe drug dependence (defined as injection of
drugs and high prevalence of overdoses) often combined
with the need for public welfare benefits and a history of
more frequent visits to physicians for somatic com-
plaints. Many IA patients experience problems in mul-
tiple domains such as; SUD, somatic and psychiatric
disorders as well as social strains. This “multiple domain
feature” is better describing the IA patients’ situation ra-
ther than the sole focus on variations within one
domain, such as the different drugs within SUD or the
different diagnoses i.e. within psychiatric disorders.
Comorbid substance use disorders and mental disorders
were observed among the majority of patients in both
groups, although the burden of psychological symptoms
(SCL-90-R and suicide attempts) was somewhat higher
in the VA group.
Characteristics of involuntarily admitted patients
The substance users included in this study were rela-
tively young, with a mean age of 29 years for IA patients.
This is somewhat younger than what was reported by a
national study of substance abusers involuntarily admit-
ted to acute psychiatric wards pursuant to the Mental
Health Care Act (mean age, 34 years) [12].
In Norway, approximately 70% of persons with SUDs
are men [24]. In accordance with this statistic, we
observed that, overall, 66% of patients were men. Al-
though the majority of substance users were male, we
observed nearly twice as many females among the IA
patients compared with the VA patients. Social workers
have reported that the reason for the relative excess of
female patients in involuntary treatment might be that
the service providers considered women more vulner-
able and exposed to violence and prostitution [25]. The
gender distribution in Norway was not found to differ
substantially from what has been found in Sweden
[16,26]. Psychiatric hospitals in Norway are character-
ized by the typical gender distribution, with more
women than men among inpatients; however, men are
more often involuntarily admitted [8,27]. Overall, 64% of
substance users involuntarily admitted to acute psychi-
atric wards pursuant to the Mental Health Care Act
were male [28].
Table 3 Current ICD-10 diagnoses of patients voluntarily and involuntarily admitted to addiction treatment centers
Diagnosis Involuntary (%) Voluntary (%) P-value
Mental disorders
No mental diagnosis 26 (40.0) 35 (25.5) 0.037
Severe mental diagnoses (F20-F39) 14 (21.5) 38 (27.7) 0.347
Other mental diagnoses (F40-F99) 25 (38.5) 64 (46.7) 0.270
F 20–90 Mental disordersa
(F 20.) Schizophrenia disorders 5 (7.7) 5 (3.6) 0.297
(F 30.) Mood disorders 9 (13.8) 33 (24.1) 0.094
(F 40.) Neurotic disorders 18 (27.7) 48 (35.0) 0.298
(F 50.) Behavioral syndromes 1 (1.5) 4 (2.9)
(F 60.) Personality disorders 8 (12.3) 22 (16.1) 0.484
(F 70.) Mental retardation 1 (1.5) 0
(F 80.) Developmental disorders 1 (1.5) 0
(F 90.) Attention-deficit hyperactivity disorders 11 (16.9) 35 (25.5) 0.172
N= 65 137
aThe number of diagnoses is higher than the number of patients because some patients have more than one mental diagnosis.
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Severity of drug dependence
IA patients exhibited more severe drug use patterns than
VA patients. Significantly more IA than VA patients had
been injecting illicit drugs during the last 6 months be-
fore admission (71% vs. 46%). Among IA patients, 70%
also reported a history of lifetime overdose experiences.
According to an overview by Bohnert et al., the lifetime
prevalence of overdoses among drug users ranges be-
tween 43% and 74% [29]. Hence, this studied population
of SUD patients appears to exhibit a particularly high-
risk drug use profile.
Polydrug diagnoses tend to be more common among IA
patients (P= 0.05). According to the EuropASI interviews,
IA patients exhibited a consistently higher prevalence of
drug use: alcohol, benzodiazepines, other sedatives, and her-
oin were consumed significantly more often. These findings
are similar to those reported in Swedish studies which
observed that IA patients were more often drug users and
polydrug users, while VA patients more often abused alcohol
[16]. The high prevalence of polydrug use is a current trend
reported in other studies of psychiatric disorders among
SUD patients [12,16]. Therefore, health service providers in
countries that are applying involuntary admission pursuant
to a social services act should take in consideration these
factors. We found that injecting illicit drugs, repeated ex-
perience of overdoses and polydrug use were all associated
with involuntary hospitalization. Injection of drugs implies
both the strongest involvement with drug use and the high-
est risk of substance-related morbidity and mortality.
Mental diagnoses and comorbidity
Psychiatric comorbidity has previously been identified
among patients admitted involuntarily pursuant to the
Mental Health Care Act [11,12,27], including the
patients admitted pursuant to the Social Services Act in
this study. Although there were no significant differences
between the types of mental diagnoses, significantly
more IA patients had no mental diagnoses (40% vs.
26%). In an overview of several studies from Sweden, it
was observed that 50% to 60% of patients seeking help
for substance use disorders did have another psychiatric
disorder [16]. Other studies from Norway and other
countries have found that among patients seeking help
for psychiatric disorders, between 24% and 70% also had
a substance abuse problem [30-34]. It has also been
shown that comorbidity contributes to re-admission for
substance use disorder patients, as well as for those with
mental disorders [27,35].
IA patients had significantly more frequent visits to
physicians for somatic complaints during the past
6 months (42% of IA patients, compared with 25% of VA
patients). This finding indicates that a pattern of severe
substance use increases the risk of somatic disorders.
High prevalence of chronic disease, acute disease, and in-
juries among SUD patients have been demonstrated by
others [36,37]. This is an often neglected problem that
health service providers should take into consideration.
SUD patients as demonstrated in this study illuminate
characteristics among a vulnerable group of patients that
often exhibit combined SUD and mental health pro-
blems, but also exhibit somatic disorders in addition.
Therefore, comorbidities appear to be particularly rele-
vant. To provide adequate care, treatment centers caring
for the needs of these and similar patients would likely
benefit from combined expertise in substance use disor-
ders, psychiatric disorders, and somatic disorders [9].
Table 4 Logistic regression analysis on involuntary admission to addiction treatment centers pursuant to the
Norwegian social services act of independent variables
Characteristics Bivariate analysis ORa (95% CI) P-value Multivariate analysis ORb (95% CI) P-value
Female gender 2.464 (1.331-4.561) 0.004 2.424 (1.174-5.003) 0.017
Public welfare benefits 3.420 (0.977-11.979) 0.054 4.029 (1.022-15.877) 0.046
Visits to physician for somatic complaintsc 2.042 (1.063-3.921) 0.032 2.208 (1.032-4.725) 0.041
Substance use disorders
Single substance reference reference
Two substances 1.304 (0.474-3.587) 0.608 0.626 (0.184-2.129) 0.454
Three or more substances 2.133 (0.933-4.876) 0.072 1.034 (0.381-2.809) 0.947
Injection drug abuse in the last 6 months 2.774 (1.453-5.296) 0.002 2.925 (1.338-6.392) 0.007
Mental disorders
No mental diagnosis reference reference
Severe mental diagnoses (F20-F39) 0.496 (0.224-1.099) 0.084 0.532 (0.196-1.443) 0.215
Other mental diagnoses (F40-F99) 0.526 (0.265-1.045) 0.066 0.679 (0.293-1.547) 0.367
Suicide attempts (lifetime) 0.525 (0.282-0.980) 0.043 0.519 (0.244-1.105) 0.089
Scl-90-R GSI 0.581 (0.363-0.929) 0.023 0.693 (0.401-1.199) 0.190
aunadjusted OR, badjusted OR, cLast 6 months before admission.
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There are some methodological considerations to
recognize when interpreting these results. First, the
comparison of the two groups, IA patients and VA
patients, may be somewhat problematic: VA patients
may generally be expected to be more motivated for
treatment and more cooperative than IA patients. How-
ever, the groups’ characteristics regarding age, education,
living conditions, and mental health status were similar.
The VA patients had all been considered to qualify for
treatment in a hospital. Second, to establish accurate
diagnosis for patients with concurrent substance abuse,
mental, and somatic disorders can be a challenge. There
will always be a risk of misdiagnosing, underreporting,
or overreporting illnesses [38].
The main objective of this study was to investigate fac-
tors associated with involuntary admission to treatment
institutions. Although the social services acts may differ in
different countries the characteristics of IA patients found
in this study may be similar for patients involuntarily ad-
mitted in other countries. We found that 60% of patients
IA pursuant to a social services act had comorbid SUD
and psychiatric disorder. This comorbidity renders treat-
ment more difficult. Patients diagnosed with comorbidities
often require longer treatment duration and more care-
fully planned care to optimize treatment outcomes. This
need presents a major challenge to the health service pro-
viders indicating the need to diagnose and treat these
patients within a highly competent system. Therefore,
clinical routines that better identify and treat SUD and
psychiatric disorders among IA patients should be given
high priority, as many of the patients would likely benefit
from integrated specialist treatment [9].
Conclusions
This study addresses the knowledge gap and focuses on
SUD patients who have been involuntarily admitted to
institutions pursuant to a social services act. Our find-
ings of which factors that are associated with involuntary
admissions to hospital of these patients may provide
useful knowledge that clinical practitioners and author-
ities in countries using involuntary admissions and treat-
ment of SUD patients would benefit from.
We found that, rather than ICD-10 diagnoses, demo-
graphic characteristics and severity of drug use (injecting
drugs, overdoses) were associated with involuntary ad-
mission to a treatment institution in this study. Women,
receiving public welfare benefits, with frequent visits to
physicians and drug injection during the past 6 months
were more likely to be associated with involuntarily
admissions to health services in accordance with the
Norwegian Social Services Act of 1993.
In sum, the factors associated with involuntary admis-
sion presented in this study indicate that “poverty”, som-
atic complaints, and a perception of females who are
using injection substances as “victims of addiction”
characterize patients involuntarily admitted to treatment
for substance use disorders. The concurrence of SUD,
mental, and somatic complaints presents a major chal-
lenge to health service providers also in an international
perspective, indicating the need to educate the health
providers and to diagnose and treat these patients within
a highly competent system.
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